Stocks/HUM

HUM three-lens brief

Evidence-based stock research on HUM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

HUM · Nightly brief
Inspect

Outperforming SPY by 24.3pp over 30 days. · RSI at 71 — technically overbought.

  • RSI at 71 — technically overbought.
  • Outperforming SPY by 24.3pp over 30 days.
  • Debt-to-equity of 74.8 — balance-sheet-heavy.

HUM closed at $215.23 (+0.13%) as of 2026-04-25. Market cap: $25.84B. P/E (trailing) 21.9. Positives: outperforming SPY by 24.3pp over 30 days.. Concerns: rSI at 71 — technically overbought.; debt-to-equity of 74.8 — balance-sheet-heavy.. Last quarter: Revenue $32.52B, net income -$796.00M, free cash flow $1.32B.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on HUM, not one.

A single reasoning model has blind spots it doesn’t know about. We examine HUMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/HUM"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath HUM brief"></iframe>